Header Logo

Connection

LORETTA NASTOUPIL to Gastrointestinal Diseases

Back to Details
This is a "connection" page, showing publications LORETTA NASTOUPIL has written about Gastrointestinal Diseases.
LORETTA NASTOUPIL
Connection Strength
0.023
Gastrointestinal Diseases
  1. A phase II study of bortezomib added to rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone in patients with previously untreated indolent non-Hodgkin's lymphoma. Br J Haematol. 2015 Nov; 171(4):539-46.
    View in: PubMed
    Score: 0.023
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.